Furthermore, a deeper understanding of the role of PrP as a receptor of amyloidogenic proteins either in the pancreas or in the brain will also shed more light on the common pathological pathways shared by neurodegenerative diseases and T2DM, benefiting the exploration of common therapeutic strategies to prevent or treat these devastating amyloid diseases. This evidence concerns the gene PRNP and neurodegenerative disease.